Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

Human medicines: European public assessment reports (EPARs)

Get the latest updates from Human medicines: European public assessment reports (EPARs) directly as they happen.

Follow now 97 followers

Latest posts

Last updated 10 days ago

Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Carcinoma, Squamous Cell, Date of authorisation: 28/06/2019, Revision: 4, Status: Authorised

10 days ago

Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Carcinoma, Squamous Cell...

Human medicines European public assessment report (EPAR): Mysimba, naltrexone / bupropion, Obesity,Overweight, Date of authorisation: 26/03/2015, Revision: 16, Status: Authorised

10 days ago

Human medicines European public assessment report (EPAR): Mysimba, naltrexone / bupropion, Obesity,Overweight...

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 13/01/2020, Revision: 3, Status: Authorised

10 days ago

Human medicines European public assessment report (EPAR): Mayzent, siponimod, Multiple Sclerosis, Relapsing-Remitting...

Human medicines European public assessment report (EPAR): Levemir, insulin detemir, Diabetes Mellitus, Date of authorisation: 01/06/2004, Revision: 28, Status: Authorised

10 days ago

Human medicines European public assessment report (EPAR): Levemir, insulin detemir, Diabetes Mellitus...